Rick Wilhiam de Camargo
◽
Marina Goulart da Silva
◽
Guilherme Cabreira Daros
◽
Fabiana Durante de Medeiros
◽
Naiana da Rosa
◽
...
Abstract
p-Cymene is a monoterpene found in over 100 plant species. It shows a
range of biological activity, including anti-inflammatory and antimicrobial
effects. It is possibly a new therapeutic alternative for autism spectrum
disorder characterized by deficits in interaction and behavioral abnormalities.
These symptoms can occur in response to maternal immune activation through
prenatal exposure to lipopolysaccharide. Thus, this study aimed to evaluate the
behavioral, memory, and biochemical effects of chronic administration of
p-cymene in an animal model of autism by prenatal maternal exposure
to lipopolysaccharide. Twenty-four pregnant Wistar rats were used, who received
100 μg/kg of lipopolysaccharide or saline intraperitoneally
(i.p.) on the 9.5 gestational day. After birth, the male offspring remained with
the mothers until weaning and underwent model validation tests on postnatal day
30. From postnatal day 31 on, chronic administration, via i.p., of saline (1
mL/kg), risperidone (0.2 mg/kg), or p-cymene (100
mg/kg) for 22 days was performed. The animals were submitted to
behavioral (postnatal day 52) and memory tests (postnatal days 52–53)
and subsequently sacrificed (postnatal day 54) when their brain structures were
removed for quantification of proinflammatory cytokines (TNF-α,
interleukin 1β, and interleukin 6). Prenatal exposure to
lipopolysaccharide significantly increased episodes of stereotyped movement
(p=0.0001) and decreased parameters of social interaction in offspring,
including sniffing, following, mounting, and allowing mounting
(p=0.0043, p<0.0001, p=0.0009, and p=0.0200,
respectively). Chronic p-cymene treatment was not significant for
behavioral, memory, and biochemical tests. However, due to their pharmacokinetic
characteristics, p-cymene nanomaterials’ formulation may be an
exciting alternative to be tested for further results.